EPISODE · Jul 29, 2026 · 2 MIN
Anvisa aprova registro de cinco novos medicamentos à base de semaglutida sintética
from As Notícias Mais Recentes da CBN · host CBN
A Anvisa aprovou nesta quarta-feira (29) o registro de cinco novos medicamentos à base de semaglutida sintética, substância que ganhou notoriedade nos últimos anos por estar presente em canetas utilizadas no tratamento do diabetes tipo 2 e da obesidade. Learn more about your ad choices. Visit megaphone.fm/adchoices
Embed this episode
NOW PLAYING
Anvisa aprova registro de cinco novos medicamentos à base de semaglutida sintética
0:00
2:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of As Notícias Mais Recentes da CBN?
This episode is 2 minutes long.
When was this As Notícias Mais Recentes da CBN episode published?
This episode was published on July 29, 2026.
Can I download this As Notícias Mais Recentes da CBN episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!